Rare diseases
Investigational molecules
Locations
Bolzanova 1604/7, 110 00 Prague, Czechia
Prof. MUDr. Petr Arenberger, DrSc. in Prague, Czechia specialises in clinical trials of conditions such as Dermatitis atopic, Vitiligo, and other specialisations. This site conducts important research.
The research site focuses on skin and connective tissue diseases, evaluating novel treatments for conditions such as atopic dermatitis and non‑segmental vitiligo.
Led by Prof. MUDr. Petr Arenberger, DrSc. in Prague, the trials aim to determine the safety and effectiveness of emerging therapies, including ANB032 and ACT‑777991, compared with placebo.
Clinical trials currently enrolling participants at this site.
Safety and efficacy of oral ACT-777991 in adults with non‑segmental vitiligo: a randomized, double‑blind, placebo‑controlled Phase 2a trial
CzechiaStudy on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis
CzechiaStudy on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis
CzechiaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
